Skip to content

ResMed Inc Price, Chart & Factor Exposure

Free Data & Analytics Access

Latest earnings: October 29, 2026 results vs estimates

ResMed Inc · E.RMD.NYSE · United States
Use symbol E.RMD.NYSE in our API & Excel add-in to retrieve this data ↓
252.83
(+0.01%)
? Live Prices updated every 5-seconds. Momentum Factor ranges from -100 to +100 and is the mean of four timeframe signals (1 Day, 1 Week, 1 Month, 3 Months), where each timeframe is +1 if return is above 0 and -1 otherwise. Trend Factor ranges from -100 to +100 and is the mean of eight signals across 1-month, 3-months, 6-months, and 1-year, using price vs moving average and moving average slope (+1 or -1). A rollover occurs when trend flips sign. Bubble Risk is the z-score of current price vs 1-year price: (Current Price - 250 trading days SMA) / (250 days price standard deviation). Values above +2.5 indicate overbought; below -2.5 oversold. Realized Volatility (20-days) is the standard deviation of daily returns over the past 20 trading days multiplied by sqrt(252).
Momentum 0%
Trend 100%
Bubble Risk LOW
Realised Volatility (20D) 21.32%

ResMed Inc Forecast

ResMed Inc short-term momentum is neutral (up over 2 of 4 look-backs: 5, 10, 20 and 30 trading days), a short-term NEUTRAL signal. The long-term trend is strongly positive (8 of 8 checks up: price above, and slope of, its 50-, 100-, 150- and 200-day averages), a long-term BUY signal. Based on 20-day realised volatility of 21.3% a year, a typical one-standard-deviation range is 245.24–260.42 over a week, 237.27–268.39 over a month and 198.92–306.74 over a year. (Signals as of 1 Nov 2026.)

ResMed Inc Price Chart

MacroFinance.ai
Market/MacroIndicatorNowChangeRange
Quantitative
ResMed Inc
Momentum (composite)
—
ⓘLatest reading of Momentum (composite).
ResMed Inc
Relative Volume (21d)
—
ⓘLatest reading of Relative Volume (21d).
ResMed Inc
Signal
0
ⓘLatest reading of Signal.
Fundamental
Valuation
ResMed Inc
P/E
22.76x
Cheap vs own history
QoQ +3.3%
YoY −11.2%
now 22.758818.09 low26.88 high
ⓘP/E As of 22 Nov 2026.See ResMed Inc returns when P/E looked like now →Opens Return analysis with the filter P/E within ±5% of today
ResMed Inc
P/S
6.32x
Mid-range vs own history
QoQ +6.5%
YoY −9.8%
now 6.32494.96 low7.4 high
ⓘP/S As of 22 Nov 2026.See ResMed Inc returns when P/S looked like now →Opens Return analysis with the filter P/S within ±5% of today
ResMed Inc
P/B
6.10x
Mid-range vs own history
QoQ +19.6%
YoY +1.2%
now 6.09624.23 low6.32 high
ⓘP/B As of 22 Nov 2026.See ResMed Inc returns when P/B looked like now →Opens Return analysis with the filter P/B within ±5% of today
ResMed Inc
EV/EBITDA
16.01x
Cheap vs own history
QoQ +5.4%
YoY −12.1%
now 16.011112.15 low18.98 high
ⓘEV/EBITDA As of 22 Nov 2026.See ResMed Inc returns when EV/EBITDA looked like now →Opens Return analysis with the filter EV/EBITDA within ±5% of today
ResMed Inc
EV/Sales
6.26x
Mid-range vs own history
QoQ +7.4%
YoY −9.5%
now 6.25514.82 low7.32 high
ⓘEV/Sales As of 22 Nov 2026.See ResMed Inc returns when EV/Sales looked like now →Opens Return analysis with the filter EV/Sales within ±5% of today
ResMed Inc
FCF Yield
4.4%
Mid-range vs own history
QoQ −9.7%
YoY −7.4%
now 4.43724.44 low6.38 high
ⓘFCF Yield As of 22 Nov 2026.See ResMed Inc returns when FCF Yield looked like now →Opens Return analysis with the filter FCF Yield within ±5% of today
ResMed Inc
Earnings Yield
4.4%
Strong vs own history
QoQ −3.2%
YoY +12.7%
now 4.39393.72 low5.53 high
ⓘEarnings Yield As of 22 Nov 2026.See ResMed Inc returns when Earnings Yield looked like now →Opens Return analysis with the filter Earnings Yield within ±5% of today
ResMed Inc
Dividend Yield
1.0%
Mid-range vs own history
QoQ −5.5%
YoY +13.1%
now 0.98420.83 low1.24 high
ⓘDividend Yield As of 22 Nov 2026.See ResMed Inc returns when Dividend Yield looked like now →Opens Return analysis with the filter Dividend Yield within ±5% of today
ResMed Inc
Market Cap
$36.3B
Mid-range vs own history
QoQ +8.0%
YoY −1.7%
now 36258.603127,488 low39,940 high
ⓘMarket Cap As of 22 Nov 2026.See ResMed Inc returns when Market Cap looked like now →Opens Return analysis with the filter Market Cap within ±5% of today
Balance-Sheet Health
ResMed Inc
Net Debt
-$400M
Mid-range vs own history
QoQ −37.8%
YoY −25.6%
now -400.164-817.34 low-400.16 high
ⓘNet Debt As of 22 Nov 2026.See ResMed Inc returns when Net Debt looked like now →Opens Return analysis with the filter Net Debt within ±5% of today
ResMed Inc
Net Debt / EBITDA
-0.18x
Mid-range vs own history
QoQ −39.8%
YoY −33.7%
now -0.1787-0.37 low-0.18 high
ⓘNet Debt / EBITDA As of 22 Nov 2026.See ResMed Inc returns when Net Debt / EBITDA looked like now →Opens Return analysis with the filter Net Debt / EBITDA within ±5% of today
ResMed Inc
Current Ratio
2.65x
Mid-range vs own history
QoQ −14.5%
YoY −8.2%
now 2.64982.65 low3.1 high
ⓘCurrent Ratio As of 22 Nov 2026.See ResMed Inc returns when Current Ratio looked like now →Opens Return analysis with the filter Current Ratio within ±5% of today
ResMed Inc
Quick Ratio
1.88x
Mid-range vs own history
QoQ −22.4%
YoY −12.0%
now 1.87851.88 low2.42 high
ⓘQuick Ratio As of 22 Nov 2026.See ResMed Inc returns when Quick Ratio looked like now →Opens Return analysis with the filter Quick Ratio within ±5% of today
ResMed Inc
Interest Coverage
43.79x
Mid-range vs own history
QoQ +13.7%
YoY −43.8%
now 43.787438.53 low77.9 high
ⓘInterest Coverage As of 22 Nov 2026.See ResMed Inc returns when Interest Coverage looked like now →Opens Return analysis with the filter Interest Coverage within ±5% of today
ResMed Inc
Debt / Equity
0.10x
Low vs own history
QoQ −18.1%
YoY −25.7%
now 0.10270.1 low0.16 high
ⓘDebt / Equity As of 22 Nov 2026.See ResMed Inc returns when Debt / Equity looked like now →Opens Return analysis with the filter Debt / Equity within ±5% of today
ResMed Inc
Piotroski F-Score
8
Strong vs own history
QoQ +33.3%
YoY +14.3%
now 86 low8 high
ⓘPiotroski F-Score As of 22 Nov 2026.See ResMed Inc returns when Piotroski F-Score looked like now →Opens Return analysis with the filter Piotroski F-Score within ±5% of today
ResMed Inc
Altman Z-Score
12.73
Mid-range vs own history
QoQ +12.4%
YoY −1.0%
now 12.726310.03 low13.78 high
ⓘAltman Z-Score As of 22 Nov 2026.See ResMed Inc returns when Altman Z-Score looked like now →Opens Return analysis with the filter Altman Z-Score within ±5% of today
  19 members-only factors: Revenue Growth, Revenue CAGR 3Y, Earnings Growth, EBITDA Growth and moreSign up
Accounting Red Flags
  21 members-only factors: Sloan Accruals, Cash-Earnings Gap, Beneish M-Score, Days Sales in Receivables Index and moreSign up
Global Risk
  22 members-only factors: MacroFinance Risk Index, VIX, VSTOXX, VIX Term Structure and moreSign up
Teal = supportive for ResMed Inc, red = a headwind, grey = neutral. Hover or tap ⓘ for how each factor works and to see returns in similar conditions.

ResMed Inc fundamentals: income statement, balance sheet & cash flow

ResMed Inc reported revenue of $5.65bn and net income of $1.52bn in FY2026, the year ended 30 June 2026 — revenue up 9.9% and net income up 8.8% on the prior year. Free cash flow was $1.65bn. These figures are as reported in the filings, not restated: 34 fiscal years and 137 quarters of history, back to June 1993. 173 FINRA short-interest settlements are published alongside them, back to June 2019.

Revenue (FY2026)
$5.65bn
+9.9%
Net income
$1.52bn
+8.8%
Gross margin
61.06%
Free cash flow
$1.65bn
-0.7%
Net debt
-$643.3m
Shares short (30 Oct 2026)
10.47m
7.05 days to cover
ResMed Inc income statement, annual, as reported · USD millions unless stated
USD millionsFY2026FY2025FY2024FY2023FY2022
Period end30 Jun 202630 Jun 202530 Jun 202430 Jun 202330 Jun 2022
Revenue5,653.45,146.34,685.34,223.03,578.1
Cost of revenue2,201.72,091.42,030.01,867.31,553.8
Gross profit3,451.73,055.02,655.32,355.72,024.3
Research & development378.3331.3307.5287.6253.6
Operating income1,886.71,685.41,319.91,131.91,000.3
EBITDA2,163.61,913.41,533.51,359.81,176.6
Interest expense29.012.645.747.422.3
Pre-tax income1,919.41,677.61,264.81,101.7960.5
Income tax396.1276.8243.8204.1181.0
Net income1,523.31,400.71,021.0897.6779.4

Download ResMed Inc fundamentals

Get the fundamentals as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_fundamentals&symbol=E.RMD.NYSE&statement=all&freq=a&format=csv&years=10
DownloadLast 10 fiscal years, no login.
The free download stops at 10 fiscal years. A free account unlocks all 34 fiscal years and 137 quarters, the filing vintages behind each number and API access.
Create free account

Figures in USD, statements as filed and FINRA consolidated short interest. A cell is left blank where the filing does not report it or where the reported figure fails the statement’s own arithmetic. Short interest is the consolidated FINRA figure for the settlement date shown, published seven to eight business days later.

Research on ResMed Inc

Explore MacroFinance macro & markets research and analysis.

Browse all financial research →

ResMed Inc Trading Strategies

58 backtested tactical asset allocation strategies hold SPY (US market) or XLV (Health Care sector), the closest tradable exposure to ResMed Inc; 28 of them are invested now. Strategies currently invested are listed first.

Hypothetical backtests over each ETF's own history; past performance does not guarantee future results. Upgrade to see every strategy's allocation and performance.

From creators

See all 58 strategies holding SPY, XLV →

Statistical Distribution of Returns

Plus

How ResMed Inc’s returns are distributed — and how they change in a given market regime.

Regime filters

Market/Macro Indicator Criteria Value And (for Between) Action

No regime filter yet — the chart below shows every period. Add a factor condition, or pick a popular regime.

MacroFinance.ai
Full return statistics
Statistic All periods Matching
  Sharpe, maximum drawdown and the full percentile table are part of Plus. Unlock with Plus
Know how ResMed Inc behaves before the regime turns Plus unlocks the full return history, unlimited factor conditions, regime-versus-baseline statistics and export — on every market, stock, ETF and index.

About ResMed Inc (United States)

ResMed Inc is a listed security in the United States. This page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data (the last 10 years as CSV or JSON, no login).

Last updated: November 22, 2026

More on ResMed Inc

Frequently asked questions

What is ResMed Inc?
ResMed Inc is a listed security in the United States. On MacroFinance its page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data.
What is the latest ResMed Inc price?
The latest close is 252.83 (1 Nov 2026), +0.01% on the day. The price at the top of the page refreshes during the trading day.
Is ResMed Inc in an uptrend?
As of 1 Nov 2026, short-term momentum is neutral (2 of 4 look-backs up: 5, 10, 20 and 30 trading days) and the long-term trend is strongly positive (8 of 8 checks up on its 50- to 200-day moving averages). Bullish when both are positive, bearish when both are negative.
How volatile is ResMed Inc?
20-day realised volatility is 21.3% a year (1 Nov 2026), which implies a typical one-standard-deviation move of about 6.2% over a month and 3.0% over a week.
What factors affect ResMed Inc?
The Factors section lists the signals, relative-value, risk-model and macro factors linked to ResMed Inc, grouped as Quantitative Factors, Fundamental Factors, Accounting Red Flags, Global Risk Factors, each with its latest reading. Some factors are open to everyone; the rest need a MacroFinance plan.
Which trading strategies trade ResMed Inc?
58 backtested tactical asset allocation strategies trade ResMed Inc through SPY, XLV; 28 of them hold it now. The Trading Strategies section lists them with their current weight, CAGR, Sharpe ratio and maximum drawdown.
How are ResMed Inc returns analysed?
The Statistical Distribution of Returns section shows the distribution of ResMed Inc daily, weekly, monthly, 2-month and 3-month returns with count, annualised average return, volatility, Sharpe ratio and maximum drawdown, and lets you filter the history by factor conditions, e.g. only periods when momentum was positive. A free account tests up to 2 factor conditions over the last 1 year of history; a Plus plan unlocks the full history, unlimited conditions, the regime statistics and the export.
Where can I download free ResMed Inc historical data?
In the Free historical data section of this page: the last 10 years of ResMed Inc daily closes as CSV or JSON, no login needed. A free account unlocks the full history, Excel and API access.

Free ResMed Inc historical data (last 10 years)

Browse or instantly download the last 10 years of ResMed Inc daily price history. A free account unlocks the full history, an Excel export with factors, and API access.

Get the data as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.RMD.NYSE&format=csv&years=10
DownloadLast 10 years, no login.
DateClose
2026-11-20235.63
2026-11-19236.88
2026-11-18242.61
2026-11-17237.85
2026-11-16238.19
2026-11-13239.53
2026-11-12238.89
2026-11-11237.87
2026-11-10233.462
2026-11-09235.088
Loading last 10 years…
The table and downloads stop at 10 years. A free account unlocks the full history, the Excel add-in and API access.
Create free account

About this stock

ResMed Inc. engages in the digital health and cloud-connected medical devices business in the United States and internationally. It operates in two segments, Sleep and Breathing Health, and Residential Care Software. The company offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry; and EasyCare Tx, a sleep lab solution. It also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; and connectivity module which provides a cellular connection between compatible ventilation devices and AirView system. In addition, the company offers Brightree solutions which are solutions and services for organizations in home medical equipment and pharmacy, orthotic and prosthetic, and home infusion; HEALTHCAREfirst solutions that offers electronic health record, software, billing and coding services, and advanced analytics that enables home health and hospice agencies to optimize clinical, financial and administrative processes; MatrixCare EHR software as a service solutions used by skilled nursing and senior living providers, life plan communities, and home health and hospice sectors; and MEDIFOX DAN software solutions that is used by residential care providers, such as home health and nursing home providers. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.